Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry
DOI 10.1016/j.eurpsy.2009.01.005

Cited by (948)

Items 201–300 of 948

  1. Entwicklungsprozess der DGPPN-Qualitätsindikatoren
    Isabell Großimlinghaus, Peter Falkai, Wolfgang Gäebel, Birgit Janssen, Daniela Reich‐Erkelenz, Thomas Wobrock, Jürgen Zielasek · 2013 · Der Nervenarzt
  2. An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study
    Davy Vancampfort, Michel Probst, Amber De Herdt, Rui Corredeira, Attilio Carraro, Dirk De Wachter, Marc D. Binder · 2013 · BMC Psychiatry
  3. Physical diseases among persons with obsessive compulsive symptoms and disorder: a general population study
    Cornelia Witthauer, Andrew Thomas Gloster, Andrea Hans Meyer, Roselind Lieb · 2014 · Social Psychiatry and Psychiatric Epidemiology
  4. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey
    Mumin Kazim Yazici, Ayşe Elif Anil Yağcioğlu, Alp Ertugrul, Nurhayat Eni, Sevilay Karahan, Ergün Karaağaoğlu, Sadberk Lale Tokgozoglu · 2010 · European Archives of Psychiatry and Clinical Neuroscience
  5. Prevalence of diabetes, obesity, and metabolic syndrome in subjects with and without schizophrenia (CURES-104)
    R. Subashini, Mohan Deepa, R Padmavati, RANGASWAMY THARA, Viswanathan Mohan · 2011 · Journal of Postgraduate Medicine
  6. Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
    Martha Sajatovic, RUTH W. ROSS, Susan N. Legacy, Matthew Byerly, John Michael Kane, Faith DiBiasi, Heather M. Fitzgerald, Christoph Ulrich Correll · 2018 · Neuropsychiatric Disease and Treatment
  7. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale
    Theodora A. Manolis, Antonis S. Manolis, Antonis S. Manolis · 2018 · Angiology
  8. Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone
    Marc D. Binder, Aurélia Mittoux, Yuan He, Joseph Peuskens · 2010 · European Archives of Psychiatry and Clinical Neuroscience
  9. Cardiovascular risk factors and 30-year cardiovascular risk in homeless adults with mental illness
    Agnes Gozdzik, Roxana Salehi, Patricia J O'Campo, Vicky Stergiopoulos, Stephen W. Hwang · 2015 · BMC Public Health
  10. The prevention of diabetes and cardiovascular disease in people with schizophrenia
    Holt, R. I. G. · 2015 · Acta Psychiatrica Scandinavica
  11. Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis
    Gorczynski, Paul, Firth, Joseph, Stubbs, Brendon, Rosenbaum, Simon, Vancampfort, Davy · 2017 · Psychiatry Research
  12. Instrument validation: hospital nurse perceptions of their Behavioral Health Care Competency
    Dana N. Rutledge, Mary E. Wickman, Diane Ash Drake, Elizabeth J. Winokur, Jeannine Loucks · 2012 · Journal of Advanced Nursing
  13. Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study
    Joseph Hayes, Golam Mohammed Khandaker, Jana J. Anderson, Daniel Mackay, Stanley Zammit, Glyn Lewis, Daniel J. Smıth, David Osborn · 2016 · Psychological Medicine
  14. Metabolic syndrome and central obesity in depression: A cross-sectional study
    Kabir Garg, Anju Agarwal, Manu Agarwal, PK Dalal, JitendraKumar Trivedi, JS Srivastava · 2016 · Indian Journal of Psychiatry
  15. Comorbidity of mental and physical disorders
    2014 · Key Issues in Mental Health
  16. Weight change during long-term treatment with lurasidone
    Jonathan M. Meyer, Yongcai Mao, Andrei Pikalov, Josephine B. Cucchiaro, Antony D Loebel · 2015 · International Clinical Psychopharmacology
  17. Schizophrenia
    Alkomiet Hasan, Peter Falkai, Isabell Lehmann, Wolfgang Gäebel · 2020 · Deutsches Ärzteblatt international
  18. Genetic association study of the P300 endophenotype in schizophrenia
    Jeroen Decoster, Marc D. Binder, Wolfgang Viechtbauer, Guy Nagels, Inez Myin‐Germeys, Jos Peuskens, Jim van Os, Ruud van Winkel · 2012 · Schizophrenia Research
  19. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
    Silvana Galderisi, Marc D. Binder, Stefano Del Prato, Andrea M. Fagiolini, Philip A. P. M. Gorwood, Stefan Leucht, Aldo Pietro Maggioni, Armida Mucci, Celso Arango · 2021 · European Psychiatry
  20. Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non‐endemic country
    Yves Jackson, Sara Castillo, Perle Hammond, Marius Besson, Anne Brawand-Bron, Diana Urzola, Jean‐Michel Gaspoz, François Chappuis · 2012 · Tropical Medicine & International Health
  21. Mental Illness and Use of Screening Mammography Among Medicaid Beneficiaries
    Siran M. Koroukian, Paul M. Bakaki, Negar Golchin, Carl V. Tyler, Sana Loue · 2012 · American Journal of Preventive Medicine
  22. EPA guidance on improving the image of psychiatry
    Anne Maria Möller-Leimkühler, H.‐J. Möller, Wolfgang Maier, Wolfgang Gäebel, Peter Falkai · 2016 · European Archives of Psychiatry and Clinical Neuroscience
  23. Cortisol and alpha-amylase assessment in psychotherapeutic intervention studies: A systematic review
    Laufer, Sebastian, Engel, Sinha, Knaevelsrud, Christine, Schumacher, Sarah · 2018 · Neuroscience & Biobehavioral Reviews
  24. Improving oral health in people with severe mental illness (SMI): A systematic review
    Alexandra Macnamara, Masuma Pervin Mishu, Mehreen Riaz Faisal, Mohammed Monirul Islam, Emily Jane Peckham · 2021 · PLoS ONE
  25. The Psychosocial Consequences of Sports Participation for Individuals with Severe Mental Illness: A Metasynthesis Review
    Andrew Soundy, Paul B Freeman, Brendon Stubbs, Michel Probst, Carolyn Roskell, Davy Vancampfort · 2015 · Advances in Psychiatry
  26. A Randomized Controlled Trial on the Efficacy of a Psychosocial Behavioral Intervention to Improve the Lifestyle of Patients With Severe Mental Disorders: Study Protocol
    Gaia Sampogna, Andrea Fiorillo, Mario Luciano, Valeria Del Vecchio, Luca Steardo, Benedetta Pocai, Marina Barone, Mario Amore, Francesca Pacitti, Liliana Dell’Osso et al. · 2018 · Frontiers in Psychiatry
  27. Impact of severe mental illness on healthcare use and health outcomes for people with type 2 diabetes: a longitudinal observational study in England
    Lu Han, Tim Doran, Richard I. G. Holt, Catherine Elizabeth Hewitt, Rowena Jacobs, Stephanie Louise Prady, Sarah Louise Alderson, David Shiers, Han-I Wang, Sue Bellass et al. · 2021 · British Journal of General Practice
  28. Metabolic syndrome in Italian patients with bipolar disorder: A 2-year follow-up study
    Virginio Salvi, Virginia D’Ambrosio, Filippo Bogetto, Giuseppe Maina · 2011 · Journal of Affective Disorders
  29. Eurofit test battery in patients with schizophrenia or schizoaffective disorder: Reliability and clinical correlates
    Davy Vancampfort, Michel Probst, Kim Sweers, Katrien Maurissen, Jan Knapen, Jan Bert Willems, Tine Heip, M.A.F. De Hert · 2011 · European Psychiatry
  30. C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in routine medical practice
    Antoni Sicras‐Mainar, Javier Rejas, Ruth Navarro‐Artieda, Milagrosa Blanca-Tamayo · 2011 · European Psychiatry
  31. Changes in Body Mass and Metabolic Profiles in Patients with First-Episode Schizophrenia Treated for 12 Months with A First-Generation Antipsychotic
    Bonginkosi Chiliza, Laila Asmal, P Oosthuizen, Evette van Niekerk, Rajiv Timothy Erasmus, Martin Kidd, Anil K. Malhotra, Robin Alexander Emsley · 2015 · European Psychiatry
  32. The Evaluation of a Telephonic Wellness Coaching Intervention for Weight Reduction and Wellness Improvement in a Community-Based Cohort of Persons With Serious Mental Illness
    Temmingh, Henk, Claassen, Amanda, van Zyl, Sandi, Carrara, Henri, Dayakalashe, Nyameka Matross, Myer, Landon, Stein, Dan J. · 2013 · Journal of Nervous & Mental Disease
  33. Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs
    Tim Moons, Stephan J. Claes, Gerard J.M. Martens, Joseph Peuskens, Karen M. J. van Loo, Jessica E. van Schijndel, Marc D. Binder, Ruud van Winkel · 2010 · Schizophrenia Research
  34. Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
    Michael J. Doane, Leona Bessonova, Haley S. Friedler, Kathleen M. Mortimer, Harry Cheng, Thomas Brecht, Amy K. O’Sullivan, Hannah Cummings, David McDonnell, Jonathan M. Meyer · 2022 · BMC Psychiatry
  35. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
    Mishal Qubad, Robert A. Bittner · 2023 · Therapeutic Advances in Psychopharmacology
  36. Difference in inflammatory cytokine production by mononuclear cells from obese and non‐obese schizophrenic patients
    Pinkhas Sirota, E. Hadi, Meir Djaldetti, Hanna Bessler · 2015 · Acta Psychiatrica Scandinavica
  37. Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study
    Massimo Clerici, Francesco Bartoli, Daniele Carretta, Cristina Crocamo, Paul Bebbington, Giuseppe Carrà · 2014 · General Hospital Psychiatry
  38. Comorbidity and multimorbidity in patients with schizophrenia and bipolar disorder: similarities and differencies.
    Ivan Oreški, Miro Jakovljević, Branka Aukst‐Margetić, Željka Crnčević Orlić, Bjanka Vuksan‐Ćusa · 2012 · PubMed
  39. Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report.
    Ana Martín-Sierra, Davy Vancampfort, Michel Probst, Julio Bobes, Katrien Maurissen, Kim Sweers, Els De Schepper, Marc De Hert · 2011 · PubMed
  40. Factors associated with regular physical activity participation among people with severe mental ill health
    Masuma Pervin Mishu, Emily Jane Peckham, Paul N. Heron, Garry Alan Tew, Brendon Stubbs, Simon M. Gilbody · 2018 · Social Psychiatry and Psychiatric Epidemiology
  41. Effectiveness of a community‐based nurse‐led lifestyle‐modification intervention for people with serious mental illness and metabolic syndrome
    Sara Fernández Guijarro, Edith Pomarol‐Clotet, M. Carmen Rubio Muñoz, Carolina Miguel García, Elena Nunilón Egea López, R. Guijarro, Lidia Castán Pérez, Maria Assumpta Rigol Cuadra · 2019 · International Journal of Mental Health Nursing
  42. Discovery and development of integrative biological markers for schizophrenia
    Viola Oertel‐Knöchel, Robert A. Bittner, Christian Knöchel, David Prvulovic, Harald Juergen Hampel · 2011 · Progress in Neurobiology
  43. Antipsychotic drug toxicology in children
    Silvio Caccia, Antonio Clavenna, Maurizio Rippa Bonati · 2011 · Expert Opinion on Drug Metabolism & Toxicology
  44. Attending to physical health in mental health services in Australia: a qualitative study of service users' experiences and expectations
    Young, Sarah J., Praskova, Anna, Hayward, Nicky, Patterson, Sue · 2017 · Health & Social Care in the Community
  45. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study
    Jussi Jaakkola, Konsta Teppo, Fausto Biancari, Olli Halminen, Jukka Putaala A, Pirjo E. Mustonen, Jari K. Haukka, Miika Linna, Janne Kinnunen, Paula Tiili et al. · 2021 · European Heart Journal - Quality of Care and Clinical Outcomes
  46. Obesity and coronary risk in patients treated with second-generation antipsychotics
    Christoph Ulrich Correll, John Michael Kane, Peter Manu · 2010 · European Archives of Psychiatry and Clinical Neuroscience
  47. Screening for Metabolic Risk Among Patients With Severe Mental Illness and Diabetes: A National Comparison
    Alex J. Mitchell, Sheila Hardy · 2013 · Psychiatric Services
  48. Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study
    Mette Søgaard, Flemming Skjøth, Jette Nordstrøm Kjældgaard, Torben Bjerregaard Larsen, Søren Pihlkjær Hjortshøj, Sam Riahi · 2017 · BMJ Open
  49. End-of-Life (Care) Perspectives and Expectations of Patients With Schizophrenia
    Kim Sweers, Bernadette Dierckx de Casterlé, Johan Detraux, Marc D. Binder · 2013 · Archives of Psychiatric Nursing
  50. Improving physical activity and diet in patients with severe mental disorders: Results from the LIFESTYLE multicentric, real-world randomized controlled trial
    Mario Luciano, Gaia Sampogna, Mario Amore, Alessandro Bertolino, Liliana Dell’Osso, Alessandro Rossi, Alberto Siracusano, Pietro Calcagno, Claudia Carmassi, Giorgio Di Lorenzo et al. · 2022 · Psychiatry Research
  51. Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review
    Fernando Cañas, Hans‐Jürgen Möller · 2010 · Expert Opinion on Drug Safety
  52. Qualitative analysis of social network influences on quitting smoking among individuals with serious mental illness
    Kelly A. Aschbrenner, John A. Naslund, Lydia E. Gill, Terence M. Hughes, A. James O’Malley, Stephen J. Bartels, Mary F. Brunette · 2017 · Journal of Mental Health
  53. The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders
    Baptiste Pignon, Chloé Tezenas du Montcel, Louise Carton, Antoine Pélissolo · 2017 · Current Psychiatry Reports
  54. Association between antipsychotic medication and clinically relevant weight change: meta-analysis
    Bea C. M. Campforts, Marjan Drukker, Joost Crins, Thérèse van Amelsvoort, Maarten Bak · 2023 · BJPsych Open
  55. Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment
    Suhailah Ali, Damian Francesco Santomauro, Alize J Ferrari, Fiona Charlson · 2023 · Epidemiology and Psychiatric Sciences
  56. Prefrontal and hippocampal brain volume deficits: role of low physical activity on brain plasticity in first-episode schizophrenia patients.
    McEwen, Sarah C., Hardy, Anthony, Ellingson, Benjamin M., Jarrahi, Behnaz, Sandhu, Navjot, Subotnik, Kenneth L., Ventura, Joseph, Nuechterlein, Keith H. · 2015 · Journal of the International Neuropsychological Society
  57. Evaluating interventions to improve somatic health in severe mental illness: a systematic review
    Fenneke M. van Hasselt, Paul F. M. Krabbe, D. G. van Ittersum, Maarten Jacobus Postma, ANTON J. M. LOONEN · 2013 · Acta Psychiatrica Scandinavica
  58. Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review
    Ewa Tumiel, Adam Wichniak, Marek Jarema, Michał Lew‐Starowicz · 2019 · Frontiers in Psychiatry
  59. Cardiometabolic Risk in First Episode Psychosis Patients
    Jo Smith, Lisa Griffiths, Marie Band, Dominic Horne · 2020 · Frontiers in Endocrinology
  60. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review
    Dolly Sud, Eileen Laughton, Robyn McAskill, Eleanor Bradley, Ian D. Maidment · 2021 · Systematic Reviews
  61. The comorbidity of hypertension and psychological distress: a study of nine countries in the former Soviet Union
    Katharine Footman, Bayard Roberts, S. Tumanov, Martin McKee · 2013 · Journal of Public Health
  62. Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis
    Kurt Buhagiar, Farid Jabbar · 2019 · Clinical Drug Investigation
  63. Care provided by general practitioners to patients with psychotic disorders: a cohort study
    Marian Oud, Jan Schuling, Klaas H. Groenier, Peter F.M. Verhaak, Cees J. Slooff, Janny H. Dekker, Betty Meyboom‐de Jong · 2010 · BMC Family Practice
  64. Improving the physical health of people with severe mental illness in a low secure forensic unit: An uncontrolled evaluation study of staff training and physical health care plans
    Mark Haddad, Sian Llewellyn‐Jones, Steve Yarnold, Alan Simpson · 2016 · International Journal of Mental Health Nursing
  65. Time-Resolved Brain-to-Heart Probabilistic Information Transfer Estimation Using Inhomogeneous Point-Process Models
    Vincenzo Catrambone, Alireza Talebi, Riccardo Barbieri, Gaetano Valenza · 2021 · IEEE Transactions on Biomedical Engineering
  66. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study
    Julio Bobes, Celso Arango, P. Aranda, Rafael Carmena, M. García-García, Javier Rejas, on behalf of the CLAMORS Study Collaborative Group · 2010 · European Psychiatry
  67. Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: results of the Metabolism in Psychiatry (MiP) Study
    Barbara B. Barton, Anja Beqiri‐Zagler, Katharina Engl, Leonie Rihs, Richard Musil · 2019 · European Archives of Psychiatry and Clinical Neuroscience
  68. Incidence and outcome of newly-diagnosed tuberculosis in schizophrenics: a 12-year, nationwide, retrospective longitudinal study
    Shu‐Chen Kuo, Yung-Tai Chen, Szu‐Yuan Li, Yi‐Tzu Lee, Albert C. Yang, Te-Li Chen, Chia-Jen Liu, Tzeng-Ji Chen, Ih Jen Su, Chang‐Phone Fung · 2013 · BMC Infectious Diseases
  69. End-of-life care in schizophrenia: a systematic review
    Joshua M. Baruth, Jacqueline B. Ho, Sohail Mohammad, Maria I. Lapid · 2020 · International Psychogeriatrics
  70. The efficacy of exercise interventions for all types of inpatients across mental health settings: A systematic review and meta-analysis of 47 studies
    Rebecca Martland, Nicole Korman, Joseph Firth, Brendon Stubbs · 2023 · Journal of Sports Sciences
  71. Effect on life expectancy of temporal sequence in a multimorbidity cluster of psychosis, diabetes, and congestive heart failure among 1·7 million individuals in Wales with 20-year follow-up: a retrospective cohort study using linked data
    Rhiannon K Owen, Jane Lyons, Ashley Akbari, Bruce Guthrie, Utkarsh Agrawal, Daniel C. Alexander, Amaya Azcoaga-Lorenzo, Anthony J. Brookes, Spiros Denaxas, Carol A. Dezateux et al. · 2023 · The Lancet Public Health
  72. Cardiovascular disease and diabetes in people with severe mental illness
    Marc D. Binder, Jacqueline M. Dekker, David A. Wood, Kai G. Kahl, Hans‐Jürgen Möller · 2009 · Revista de Psiquiatría y Salud Mental (English Edition)
  73. A double-edged sword: review of the interplay between physical health and mental health
    Caragh L. Behan, R. Doyle, Siobhán Masterson, David Shiers, Mary Clarke · 2014 · Irish Journal of Medical Science (1971 -)
  74. Telephone-Delivered Physical Activity Intervention for Individuals With Serious Mental Illness
    Heeyoung Lee, I. Kane, J. Brar, S. Sereika · 2014 · Journal of the American Psychiatric Nurses Association
  75. The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies
    Weiss, Catherine, Weiller, Emmanuelle, Baker, Ross A., Duffy, Ruth A., Gwin, Keva K., Zhang, Peter, McQuade, Robert D. · 2018 · International Clinical Psychopharmacology
  76. Screening for Metabolic Syndrome in Older Patients with Severe Mental Illness
    Hugo Konz, Paul David Meesters, Nadine P.G. Paans, Daniël S. Van Grootheest, Hannie C. Comijs, Max L. Stek, Annemiek Dols · 2014 · American Journal of Geriatric Psychiatry
  77. Metabolic risk reduction in patients with schizophrenia treated with antipsychotics: recommendations of the Polish Psychiatric Association
    Adam Wichniak, Dominika Dudek, Janusz Heitzman, Agnieszka Kapłon‐Cieślicka, Artur Mamcarz, Jerzy Samochowiec, Agata Szulc, Przemysław Bieńkowski · 2019 · Psychiatria Polska
  78. Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
    Hesham Shamshoum, Kyle D. Medak, David Charles Wright · 2020 · Behavioural Brain Research
  79. Quality Assessment of Physical Activity Recommendations Within Clinical Practice Guidelines for the Prevention and Treatment of Cardio-metabolic Risk Factors in People With Schizophrenia
    Davy Vancampfort, Kim Sweers, Michel Probst, Alex J. Mitchell, Jan Knapen, Marc D. Binder · 2011 · Community Mental Health Journal
  80. A 12-Week Weight Reduction Intervention for Overweight Individuals Taking Antipsychotic Medications
    C. Green, S. Janoff, Bobbi Jo H. Yarborough, Micah T. Yarborough · 2014 · Community mental health journal
  81. European Psychiatric Association (EPA) guidance on quality assurance in mental healthcare
    Wolfgang Gäebel, Isabell Großimlinghaus, Reinhard Heun, Birgit Janssen, Bert Johnson, Tamás Kurimay, P. Montellano, Matthijs Muijen, Povl Munk‐Jørgensen, Wulf Rössler A et al. · 2015 · European Psychiatry
  82. The association of the metabolic profile in diabetes mellitus type 2 patients with obsessive-compulsive symptomatology and depressive symptomatology: New insights
    Konstantinos A. Kontoangelos, Athanasios E. Raptis, Charalabos Papageorgiou, George N. Papadimitriou, Andreas D. Rabavilas, George Dimitriadis, S. Raptis · 2012 · International Journal of Psychiatry in Clinical Practice
  83. Pericardial adipose tissue and the metabolic syndrome is increased in patients with chronic major depressive disorder compared to acute depression and controls
    K.G. Kahl, J. Herrmann, Brendon Stubbs, Tillmann H. C. Krüger, J. Cordes, Michael Deuschle, Ulrich Schweiger, Katja Hüper, Saskia Helm, Anna Birkenstock et al. · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  84. Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder
    K. Nemani, M. Greene, Melissa Ulloa, Brenda Vincenzi, P. Copeland, Sulaiman Al-Khadari, D. Henderson · 2017 · Clinical Schizophrenia and Related Psychoses
  85. The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
    Konsta Teppo, Jussi Jaakkola, Mika Lehto, Fausto Biancari, Juhani K.E. Airaksinen · 2021 · American Journal of Preventive Cardiology
  86. How to improve the physical health of people with severe mental illness? A multicentric randomized controlled trial on the efficacy of a lifestyle group intervention
    Mario Luciano, Gaia Sampogna, Mario Amore, Ileana Andriola, Pietro Calcagno, Claudia Carmassi, Valeria Del Vecchio, Liliana Dell’Osso, Giorgio Di Lorenzo, Barbara Gelao et al. · 2021 · European Psychiatry
  87. Serious Mental Illness and the Role of Primary Care
    Claire Planner, Linda L Gask, Siobhán Reilly · 2014 · Current Psychiatry Reports
  88. Economic evaluations in bipolar disorder: a systematic review and critical appraisal
    Anees Ahmed Abdul Pari, Judit Simon, Jane L. Wolstenholme, John Richard Geddes, Guy M. Goodwin · 2014 · Bipolar Disorders
  89. Military service and other socioecological factors influencing weight and health behavior change in overweight and obese Veterans: a qualitative study to inform intervention development within primary care at the United States Veterans Health Administration
    Melanie R Jay, Katrina F. Mateo, Allison Patricia Squires, Adina L. Kalet, Scott E. Sherman · 2016 · BMC Obesity
  90. Preferences for Smoking Cessation Support from Family and Friends Among Adults with Serious Mental Illness
    Kelly A. Aschbrenner, John A. Naslund, Lydia E. Gill, Stephen J. Bartels, A. James O’Malley, Mary F. Brunette · 2017 · Psychiatric Quarterly
  91. Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia
    Aurélie Delacrétaz, Frederik Vandenberghe, Mehdi Gholam‐Rezaee, Núria Saigí-Morgui, Anaïs Glatard, Jacques Thonney, Alessandra Solida-Tozzi, Stéphane Kolly, Sylfa Fassassi Gallo, Philipp Baumann et al. · 2017 · Journal of clinical lipidology
  92. Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication
    Rachel Morell, Jackie Curtis, Andrew Watkins, Josephine Poole, Hamish Fibbins, Elisa Rossimel, Mark Gerrard, Annette White, Scott B. Teasdale, Philip B. Ward et al. · 2019 · Psychiatry Research
  93. Nurse‐assessed metabolic monitoring: A file audit of risk factor prevalence and impact of an intervention to enhance measurement of waist circumference
    Simon Rosenbaum, Sukh Nijjar, Andrew Watkins, Natasha Garwood, Catherine Sherrington, Anne Tiedemann · 2014 · International Journal of Mental Health Nursing
  94. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Oliver Kozumplik, Suzana Uzun, Miro Jakovljević · 2010 · PubMed
  95. Increased risk of incident atrial fibrillation in young adults with mental disorders: A nationwide population-based study
    Hyun Jin Ahn, So‐Ryoung Lee, Eue‐Keun Choi, Nan Young Bae, Hyo‐Jeong Ahn, Soonil Kwon, Seung‐Woo Lee, Kyung-Do Han, Seil Oh, Gregory Y.H. Lip · 2022 · Heart Rhythm
  96. One-year efficacy of a lifestyle behavioural intervention on physical and mental health in people with severe mental disorders: results from a randomized controlled trial
    Mario Luciano, Gaia Sampogna, Enrico D’Ambrosio, Antonio Rampino, Mario Amore, P. Calcagno, Alessandro Rossi, Rodolfo Rossi, Claudia Carmassi, Liliana Dell’Osso et al. · 2023 · European Archives of Psychiatry and Clinical Neuroscience
  97. Prevalence of the metabolic syndrome in men and women with alcohol dependence: results from a cross‐sectional study during behavioural treatment in a controlled environment
    Kai G. Kahl, Wiebke Greggersen, Ulrich Schweiger, Joachim Cordes, Christoph Ulrich Correll, Jessica Ristow, Juliane Burow, Corinna Findel, Anne M. Stoll, Chakrapani Balijepalli et al. · 2010 · Addiction
  98. Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe
    G. Papageorgiou, F. Cañas, Mathias Zink, Alessandro Rossi · 2011 · European Psychiatry
  99. Metabolic and Cardiovascular Adverse Effects Associated with Treatment with Antipsychotic Drugs
    Shen-Chieh Chang, Mong‐Liang Lu · 2012 · Journal of Experimental & Clinical Medicine
  100. Who is responsible for metabolic screening for mental health clients taking antipsychotic medications?
    Tamara Ward, Dianne Wynaden, Karen Heslop · 2017 · International Journal of Mental Health Nursing